How Aspirin Damages the Stomach Lining
Aspirin inhibits cyclooxygenase (COX) enzymes, blocking prostaglandin synthesis. Prostaglandins normally protect the gastric mucosa by stimulating mucus and bicarbonate secretion, maintaining blood flow, and regulating acid production. This inhibition leads to reduced mucosal defenses, making the stomach lining vulnerable to acid and pepsin erosion.[1][2]
Types of Changes and Lesions Observed
- Erosions: Superficial defects in the epithelium, often multiple and pinpoint-sized, appearing within hours of exposure. These lack full-thickness involvement.
- Ulcers: Deeper craters penetrating the muscularis mucosa, typically 0.3-1 cm, forming over days with chronic use.
- Hemorrhagic spots: Petechiae or diffuse oozing from damaged capillaries.
- Gastritis: Inflammation with edema, hyperemia, and leukocyte infiltration in the mucosa.[3][4]
Endoscopically, low-dose aspirin (e.g., 81 mg) causes erosions in 20-40% of users after 1-4 weeks; higher doses (325 mg+) increase rates to 50-80%.[5]
Mechanism Step-by-Step
- Topical irritation from aspirin's acidity (pKa 3.5) disrupts the hydrophobic mucus layer.
- Systemic COX-1 inhibition depletes protective prostaglandins (PGE2, PGI2).
- Back-diffusion of H+ ions into mucosa, causing ischemia and cell death.
- Leukotriene overproduction promotes further inflammation.[2][6]
These effects are dose- and duration-dependent, worsening with NSAIDs or Helicobacter pylori infection.
Timeframe for Changes
Acute: Erosions visible in 1-24 hours post-dose.
Subacute (1-7 days): Ulcers and bleeding emerge.
Chronic (>1 month): Risk of perforation or strictures rises 2-4 fold.[4][7]
Factors Increasing Damage
- High dose (>325 mg/day).
- Concurrent alcohol, steroids, or anticoagulants.
- Age >65, prior ulcer history, or smoking.[5][8]
How to Detect and Monitor
Upper endoscopy confirms changes (e.g., Lanza score rates erosion severity). Fecal occult blood tests detect subclinical bleeding in 10-20% of users.[3]
Reversibility and Prevention
Damage often heals within 1-2 weeks after stopping, but chronic use risks persistent ulcers. Proton pump inhibitors (PPIs) like omeprazole reduce risk by 70-90% by suppressing acid. Misoprostol or enteric-coated formulations offer partial protection.[7][9]
Sources
[1] PubMed: Aspirin and gastric mucosa
[2] Nature Reviews: NSAID gastropathy
[3] NEJM: Aspirin-induced gastric injury
[4] Gastroenterology: Endoscopic findings
[5] Lancet: Low-dose aspirin risks
[6] Pharmacology Reviews: COX inhibition
[7] Annals of Internal Medicine: Prevention strategies
[8] American Journal of Gastroenterology: Risk factors
[9] Cochrane: PPI co-therapy